Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
about
Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancerGeometric attributes of retaining glycosyltransferase enzymes favor an orthogonal mechanismBacteria and cancer: cause, coincidence or cure? A reviewThe salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjectsThe role of immunoglobulin superfamily cell adhesion molecules in cancer metastasisThe human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene familySynergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis.Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression.Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signallingHeparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasisExpression of peanut agglutinin-binding mucin-type glycoprotein in human esophageal squamous cell carcinoma as a markerThe Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer ProgressionRole of Glycans in Cancer Cells Undergoing Epithelial-Mesenchymal TransitionMolecular recognition of gangliosides and their potential for cancer immunotherapiesControl of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene familyA Quest to Identify Prostate Cancer Circulating Biomarkers with a Bench-to-Bedside PotentialProbing the Substrate Specificity of Golgi α-Mannosidase II by Use of Synthetic Oligosaccharides and a Catalytic Nucleophile MutantGanglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouseN -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumoursRegulation of differentiation- and proliferation-inducers on Lewis antigens, alpha-fucosyltransferase and metastatic potential in hepatocarcinoma cellsTriptolide downregulates human GD3 synthase (hST8Sia I) gene expression in SK-MEL-2 human melanoma cellsLocalization and imaging of gangliosides in mouse brain tissue sections by laserspray ionization inletLipidomics reveals dramatic lipid compositional changes in the maturing postnatal lungAssessment of total sialic acid and lipid-bound sialic acid in management of brain tumors.Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisx and Lewisx.The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer.Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1.Alterations in the serum glycome due to metastatic prostate cancerSialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.The high affinity selectin glycan ligand C2-O-sLex and mRNA transcripts of the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT1) gene are highly expressed in human colorectal adenocarcinomas.In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction.Glycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies.Fatty acid 2-Hydroxylation in mammalian sphingolipid biologyO Labeling for a Quantitative Proteomic Analysis of Glycoproteins in Hepatocellular Carcinoma.Modulation of growth factor signaling by gangliosides: positive or negative?C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells.Low complex ganglioside expression characterizes human neuroblastoma cell lines.A carbohydrate-grafted nanovesicle with activatable optical and acoustic contrasts for dual modality high performance tumor imagingGanglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth.Differential analysis of N-glycoproteome between hepatocellular carcinoma and normal human liver tissues by combination of multiple protease digestion and solid phase based labeling.
P2860
Q21090050-2A6C8337-8651-4103-A80D-5DDABD066DCAQ21090730-E62DD37A-585D-4208-A0DA-E19AD905352EQ21245476-DDF124D7-12FD-4D5F-86E5-DFA52FC31464Q21245477-8D7BDD33-4A8E-4436-8116-97C7AB6D40DBQ21296664-A5DD16E1-26D8-4B1E-BB06-A83FE1541F9DQ22008688-10156A86-3F8A-4914-BF68-0A8B8360B7D2Q24529958-A5B44540-B3EB-4F55-A0C7-1273AA70F432Q24533672-126628EE-B10B-4C50-AB83-106FC63F4DD7Q24541434-76358BAD-74F9-48C4-BCB2-E509406BC2A8Q24630993-B362236F-BA39-4852-9AB5-9507B902736CQ24797979-9D39BAB6-1125-4A2F-9A9C-E40AD86C00B1Q26750877-488D8376-98C6-46B6-BAA7-884D62BFDDCBQ26765748-B4C4A8DE-B01C-4420-8A2D-FB215A084CD5Q26830588-6858B92A-556C-4673-9C73-1BC34E72AB16Q26864268-FB19AFE4-746B-4337-BB83-E6F7D79768DEQ27022638-5C994A4D-8A53-403E-B557-3F18B974FADFQ27650852-FDA7B2E5-CC36-4C26-A12B-DF80E42F4C84Q28344350-CD9FF808-E7DB-4621-99A1-1FC015D87CAFQ28362969-86D38D2E-76F2-4293-9161-627A71275524Q28366050-988B0E14-9C44-4916-AF62-8C49405EEF92Q28385576-7C7FACA1-E7D3-4326-B45B-46AF276FE254Q28728658-D1A41545-05E2-438C-8EA7-050BE87023D7Q28817762-7DF7DADF-428A-46FF-9FB6-91FE224431B7Q30483180-B499CF12-48F7-40CF-B6C2-2AEB06F2DB00Q30709503-98AEA7C6-7D4C-4AE3-A6AF-92972DB91D8CQ33229926-CCCEC0C9-C828-401B-8DA1-B983EB1662E0Q33261868-AD737814-AA5B-4635-B022-B31B776A4F96Q33282042-FA684768-BF21-418E-A0BE-7FB636646A46Q33290245-E1FFD4EF-4000-4746-85B5-0E4458C27589Q33415704-7CBA4ED3-74CD-483E-BA71-0D019A7897DBQ33569192-E1FAEB1C-1237-4D13-BC0F-E0DB80E1D983Q33659849-D5887F8B-01B5-4DD8-AC4B-C0773E194BEAQ33678737-9A465316-3198-49C4-B6C8-84969B522F07Q33760930-71755F62-126B-4391-8278-DBC193790E46Q33779395-8D2FB7FA-933F-44FC-8F10-9F604AEA5523Q33809540-F201A6F3-BCBD-4B74-8586-817E8FC455A4Q33837556-FCE8F965-0188-4EFE-88B5-A61F23EC84FAQ33869355-4EED4E25-7B88-490F-B6EA-0575B86780FFQ33893675-86259EAD-CA6A-43ED-AE71-D7F0DC0CD165Q33958684-F95ACC17-E46F-436A-B244-BD4865B6C793
P2860
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
@en
type
label
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
@en
prefLabel
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
@en
P1433
P1476
Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
@en
P2093
Hakomori S
P304
P407
P577
1996-12-01T00:00:00Z